Skip to main
USPH
USPH logo

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy Inc has demonstrated strong financial performance, with the industrial injury prevention (IIP) segment reporting an overall revenue growth of 29.9%, and an impressive 12.9% growth when excluding mergers and acquisitions impact. In the third quarter, the company's non-CMS pricing increased by 3.9% compared to the same period in the previous fiscal year, showcasing its ability to adapt pricing strategies effectively despite Medicare cuts, which still resulted in a notable 3.2% revenue increase. Additionally, the volume of workers' compensation visits surged by over 16%, contributing to nearly 19% revenue growth year-over-year, reflecting strong demand for its services across both physical therapy operations and industrial injury prevention.

Bears say

The financial outlook for US Physical Therapy Inc. is negative due to anticipated reimbursement rate headwinds of 2.8% for outpatient physical therapy services in 2025, which could impact revenue generation. While reported revenue of $166.3 million slightly exceeded estimates, the company's efforts to improve efficiency, including the closure of 32 underperforming facilities, indicate ongoing operational challenges. Furthermore, Congress's potential delays in providing relief from proposed rate cuts could exacerbate revenue pressures in the coming years.

USPH has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 10 analysts, USPH has a Buy consensus rating as of Jun 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.10, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.10, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.